Skip to main content
DAQING HUAKE CO.,LTD logo

DAQING HUAKE CO.,LTD — Investor Relations & Filings

Ticker · 000985 ISIN · CNE000001402 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,324 across all filing types
Latest filing 2017-12-01 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 000985

About DAQING HUAKE CO.,LTD

https://www.huake.com

Daqing Huake Co., Ltd. specializes in the deep processing of petrochemical products and the production of fine chemicals. The company's core business activities involve the research, development, manufacturing, and distribution of a diverse range of chemical materials. Key product lines include C5 and C9 petroleum resins, which are widely used in adhesives, coatings, and rubber compounding. Additionally, the company produces high-purity acetonitrile, isopropyl alcohol, and polypropylene. Daqing Huake leverages its proximity to major oil and gas resources to maintain a stable supply chain and focuses on technological innovation to enhance product quality. Its products serve various industrial sectors, including plastics, pharmaceuticals, and chemical synthesis, catering to both domestic and international markets.

Recent filings

Filing Released Lang Actions
关于召开2017年第三次临时股东大会的提示性公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement about the convening of the 2017 third extraordinary general meeting of shareholders for the company 大庆华科股份有限公司. It includes information about the meeting date, voting procedures (including online voting), proposal details, registration methods, and proxy forms. There is no financial data, earnings information, or management discussion. The document is primarily a notice to shareholders about the meeting and how to participate and vote on proposals. It is not a report or transcript but a formal meeting notice and voting instruction. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice about the meeting and voting procedures rather than the solicitation materials or proxy statement itself, it is best classified as a Declaration of Voting Results & Voting Rights Announcements (DVA) because it includes detailed voting instructions and proposal information for the shareholder meeting. The document length is under 5,000 characters, but it is not merely announcing a report publication; it is the actual meeting notice and voting instructions. Hence, the best fit is DVA.
2017-12-01 Chinese
关于药业分公司资产转让的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the proposed transfer of assets of a pharmaceutical division of the company. It includes details about the asset transfer plan, board meeting approvals, asset valuation, and the impact on the company. It does not contain full financial statements or comprehensive financial performance data. The document is a disclosure about a capital transaction (asset transfer) and the process involved, including regulatory compliance and shareholder approval requirements. It is not a full annual or interim report, nor is it a simple announcement of a report publication. The content fits best under Capital/Financing Update (CAP) as it relates to company fundraising, financing activities, or capital structure changes, specifically asset transfer.
2017-11-20 Chinese
关于召开2017年第三次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about convening the 2017 third extraordinary general meeting of shareholders for the company 大庆华科股份有限公司. It includes details about the meeting time, location, voting procedures (including online voting), registration methods, and the agenda (asset transfer proposal). It does not contain financial statements or results, nor is it a transcript or report of the meeting outcomes. The document is an announcement informing shareholders about the upcoming meeting and how to participate. The document length is 3406 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2017-11-20 Chinese
拟转让资产所涉及的资产组合价值项目资产评估报告
Audit Report / Information Classification · 95% confidence The document is an asset valuation report prepared by an asset evaluation company for Daqing Huake Co., Ltd. regarding the assets proposed for transfer. It includes detailed asset descriptions, valuation methods, legal and regulatory references, and a valuation conclusion as of December 31, 2016. The document is a comprehensive standalone asset appraisal report, not an announcement or summary. It does not fit categories like Annual Report, Earnings Release, or Management Reports. It is specifically an asset evaluation report related to a transaction or asset transfer. According to the filing definitions, this type of document aligns best with Audit Report / Information (AR), which includes applied accounting principles and results of internal or regulatory evaluations excluding full annual reports. The document is not a full annual report but a detailed asset evaluation report, so AR is the most appropriate classification. The document length (15,000 characters) and content confirm it is a full report, not a brief announcement or certification. FY 2016
2017-11-20 Chinese
第七届董事会2017年第一次临时会议决议更正公告
Regulatory Filings Classification · 95% confidence The document is a correction announcement regarding a previous board meeting resolution about asset transfer and related shareholder meeting arrangements. It includes voting results from the board meeting and references a future shareholder meeting for approval. The document is short (1236 characters) and serves to correct previously disclosed information rather than presenting a full report or financial data. It does not contain financial statements or detailed financial analysis. It is not a full Annual Report, Interim Report, or Earnings Release. It is not a Management Report or Investor Presentation. It is not a Director's Dealing or Major Shareholding Notification. The document is an announcement related to board decisions and meeting resolutions, specifically correcting a prior announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and corrections that do not fit other specific categories.
2017-11-20 Chinese
第七届董事会2017年第一次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a board meeting resolution by the company 大庆华科股份有限公司. It details the meeting date, attendance, and the decision to approve the transfer of assets of a pharmaceutical division. It includes references to independent directors' opinions and an asset valuation report. There is no financial statement or comprehensive financial data presented, nor is it a full annual or interim report. The document is clearly about board decisions and management actions regarding asset transfer, which fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication but a substantive announcement of a board resolution. Therefore, the classification is MANG with high confidence.
2017-11-17 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.